Abstract
Inborn errors involving the oxidative metabolism of fatty acids may present clinically with a Reye syndrome-like picture. This case report of a patient with medium-chain acyl CoA dehydrogenase (MCAD) deficiency illustrates that electron microscopy may help to differentiate this disorder from Reye syndrome even if a liver biopsy is performed in a patient who recovered from an acute metabolic decompensation. Together with this case, a review of the few reports in the literature of pathological findings in MCAD deficiency is given. Changes uncharacteristic for Reye syndrome are a largedroplet steatosis and the presence of distinctive mitochondrial abnormalities on electron microscopy. The detection of an electron dense mitochondrial matrix and a widened space of inner mitochondrial membranes rules out Reye syndrome and is suggestive of a disorder of mitochondrial fatty acid oxidation.
Similar content being viewed by others
Abbreviations
- MCAD:
-
medium-chain acyl CoA dehydrogenase
References
Coates PM, Hale DE, Stanley CA, Corkey BE, Cortner JA (1985) Genetic deficiency of medium-chain acyl-CoA dehydrogenase: studies in cultured skin fibroblasts and peripheral mononuclear leukocytes. Pediatr Res 19:671–676
Lake BD, Clayton PT, Leonhard JV, Bhuiyan AKMJ, Aynsley-Green A (1987) Ultrastructure of liver in inherited disorders of fat oxidation. Lancet I:382–383
Partin JC, Schubert WK, Partin JS (1971) Mitochondrial ultrastructure in Reye's syndrome (encephalopathy and fatty degeneration of the viscera). N Engl J Med 285:1339–1344
Phillips MJ, Poucell S, Patterson J, Valencia P (1987) The liver. An atlas and text of ultrastructural pathology. Raven Press, New York
Rinaldo P, O'Shea JJ, Coates PM, Hale DE, Stanley CA, Tanaka K (1988) Medium-chain acyl CoA dehydrogenase deficiency. Diagnosis by stable-isotype dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionyl-glycine. N Engl J Med 319:1308–1313
Roe CR, Millington DS, Maltby DA, Bohan TP, Kahler SG, Chalmers RA (1985) Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl CoA dehydrogenase deficiency. Pediatr Res 19:459–466
Roe CR, Millington DS, Maltby DA, Kinnebrew P (1986) Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children of sudden infant death or Reye-like syndrome. J Pediatr 108:13–18
Rumsby G, Seakins JWT, Leonard JV (1986) A simple screening test for medium-chain acyl CoA dehydrogenase deficiency. Lancet II:467
Taubman B, Hale DE, Kelley RI (1987) Familial Reye-like syndrome: a presentation of medium-chain acyl-CoA dehydrogenase deficiency. Pediatrics 79:382–385
Treem WR, Witzleben CA, Piccoli DA, Stanley CA, Hale DE, Coates PM, Watkins JB (1986) Medium-chain and longchain acyl-CoA dehydrogenase deficiency: clinical and ultrastructural differentiation from Reye syndrome. Hepatology 6:1270–1278
Vianey-Liaud C, Divry P, Gregersen N, Mathieu M (1987) The inborn errors of mitochondrial fatty acid oxidation. J Inherited Metab Dis 10 [Suppl 1]:159–198
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Santer, R., Schmidt-Sommerfeld, E., Leung, Y.K. et al. Medium-chain acyl CoA dehydrogenase deficiency: Electron microscopic differentiation from Reye syndrome. Eur J Pediatr 150, 111–114 (1990). https://doi.org/10.1007/BF02072051
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02072051